And now, a seaweed-based nutraceutical cure for fatty liver disease Business Standard dated 27th September 2022

CMFRI, Library (2022) And now, a seaweed-based nutraceutical cure for fatty liver disease Business Standard dated 27th September 2022. Business Standard.

[img] Text
Business Standard_27-09-2022.pdf

Download (155kB)
Official URL: https://www.business-standard.com/article/current-...
Related URLs:

    Abstract

    Kochi: The Central Marine Fisheries Research Institute (CMFRI) based in Kochi has come up with a nutraceutical product from select seaweeds for the treatment of non-alcoholic fatty liver disease (NAFLD). Named Cadalmin LivCure extract, the product is a unique blend of 100 percent natural bioactive ingredients extracted from seaweeds to improve liver health.

    Item Type: Article
    Subjects: Algae > Seaweed
    CMFRI News Clippings
    Divisions: Library & Documentation
    Depositing User: Mr. Augustine Sipson N A
    Date Deposited: 03 Oct 2022 04:08
    Last Modified: 03 Oct 2022 04:08
    URI: http://eprints.cmfri.org.in/id/eprint/16294

    Actions (login required)

    View Item View Item